1. Home
  2. LCFY vs SNOA Comparison

LCFY vs SNOA Comparison

Compare LCFY & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • SNOA
  • Stock Information
  • Founded
  • LCFY 2009
  • SNOA 1999
  • Country
  • LCFY Australia
  • SNOA United States
  • Employees
  • LCFY N/A
  • SNOA N/A
  • Industry
  • LCFY
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCFY
  • SNOA Health Care
  • Exchange
  • LCFY Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • LCFY 7.0M
  • SNOA 6.4M
  • IPO Year
  • LCFY 2022
  • SNOA 2007
  • Fundamental
  • Price
  • LCFY $4.05
  • SNOA $3.47
  • Analyst Decision
  • LCFY
  • SNOA
  • Analyst Count
  • LCFY 0
  • SNOA 0
  • Target Price
  • LCFY N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • LCFY 17.7K
  • SNOA 70.1K
  • Earning Date
  • LCFY 06-10-2025
  • SNOA 06-16-2025
  • Dividend Yield
  • LCFY N/A
  • SNOA N/A
  • EPS Growth
  • LCFY N/A
  • SNOA N/A
  • EPS
  • LCFY N/A
  • SNOA N/A
  • Revenue
  • LCFY $2,668,385.00
  • SNOA $13,973,000.00
  • Revenue This Year
  • LCFY N/A
  • SNOA $23.89
  • Revenue Next Year
  • LCFY N/A
  • SNOA $25.45
  • P/E Ratio
  • LCFY N/A
  • SNOA N/A
  • Revenue Growth
  • LCFY N/A
  • SNOA 13.51
  • 52 Week Low
  • LCFY $2.20
  • SNOA $1.75
  • 52 Week High
  • LCFY $11.23
  • SNOA $9.37
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 42.34
  • SNOA 59.16
  • Support Level
  • LCFY $4.34
  • SNOA $3.05
  • Resistance Level
  • LCFY $4.32
  • SNOA $3.41
  • Average True Range (ATR)
  • LCFY 0.23
  • SNOA 0.20
  • MACD
  • LCFY -0.04
  • SNOA -0.00
  • Stochastic Oscillator
  • LCFY 5.04
  • SNOA 79.31

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: